Background/Aims/Objectives: We have investigated the clinical and physiological effects of Transfer Capacitive Resistive Energy (TCARE) therapy on men with Peyronie's disease (PD). Methods: Ninety-six men with PD have been randomized in a 2:1 ratio to receive 3 sessions of TCARE therapy or sham therapy. Pain, penile curvature and erectile function have been assessed before the first treatment and up to 9 months after the end of treatment, using the Visual Analogue Scale for the pain, a goniometer to measure the degree of curvature using at-home photography and an International Index of Erectile Function (IIEF-5) questionnaire. Results: A significant pain reduction at the end of the treatment in 51 (79.6%) patients (p < 0.01) of the treated group was observed. No significant improvements in the sham group (p = 0.23) have been observed. No statistical differences in the degree of curvature have been observed in both groups. No statistical improvements have been observed in the IIEF-5 questionnaire. Adverse events have not been reported. Conclusion: This is, to our knowledge, the first randomized, single-blind, sham-controlled study that shows that TCARE has a positive short-term clinical effect on pain in patients with PD. The feasibility and tolerability of this treatment produce an attractive new therapeutic option for men with PD.

Keywords:
Induratio penis plastic, Transfer capacitive resistive energy, Penis plaque, Penile pain, Erectile failure, Peyronie’s disease
1.
Pavone C, Napoli G, Caruana G, Alonge V, Usala M, Abbadessa D: Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study. BJU Int 2012;110:117-121.
2.
Paulis G, Barletta D, Turchi P, Vitarelli A, Dachille G, Fabiani A, Gennaro R: Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study. Res Rep Urol 2015;8:1-10.
3.
Park TY, Jeong HG, Park JJ, Chae JY, Kim JW, Oh MM, Park HS, Kim JJ, Moon du G: The efficacy of medical treatment of Peyronie's disease: potassium para-aminobenzoate monotherapy vs. combination therapy with tamoxifen, L-carnitine, and phosphodiesterase type 5 inhibitor. World J Mens Health 2016;34:40-46.
4.
Chung E: Peyronie's disease and low intensity shock wave therapy: clinical outcomes and patient satisfaction rate in an open-label single arm prospective study in Australian men. Korean J Urol 2015;56:775-780.
5.
Ralph D, Gonzalez-Cadavid N, Mirone V, Perovic S, Sohn M, Usta M, Levine L: The management of Peyronie's disease: intralesional collagenase injections in patients with Peyronie's disease: do they IMPRESS and can we afford them? Terry T. BJU Int 2015;116:503-504.
6.
Gribaudo CG, Astegiano P, Canala GL, Ganzit GP: Trattamento con ipertermia a trasferimento energetico resistivo capacitivo di lesioni muscolo scheletriche acute e croniche: risultati preliminari in Radiazioni in medicina: qualità e sicurezza. Atti del congresso - Fisica sanitaria - n.1/197 gennaio/marzo, pp 379-381.
7.
Cole AJ, Eagleston RA, Herring SA: The benefits of deep heat. Phys Sportsmed 1994;22:76-88.
8.
Mondardini P: Nuove metodologie nel trattamento della patologia muscolare traumatica dell'atleta. La T.E.C.A.R. terapia. Med Spor 1999;52:201-213.
9.
Pavone C, Castrianni D, Romeo S, Napoli E, Usala M, Gambino G, Scaturro D, Letizia Mauro G, Il Trasferimento Energetico Capacitivo Resistivo (TECAR) nella terapia dell'Induratio Penis Plastica: studio pilota di fase uno sulla tollerabilità, sulla sicurezza e sull'applicabilità della tecnica. Quali altri risvolti sorprendenti. Urologia 2013;80:148-153.
10.
Pavone C, Curto F, Anello G, Serretta V, Almasio PL, Pavone-Macaluso M: Prospective, randomized, crossover comparison of sublingual apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunction. J Urol 2008;179(5 suppl):S92-S94.
11.
Giacchetto C, De Grande G, Vicari E, La Vignera G, Cutrale G, Pavone C, Minì S, Dammino S, Panella P, Mastroeni F, Turiano G, Paola Q, Di Trapani D, Lanzafame F, Cirota G, Allegro R: Valutazione della terapia a lungo termine con Tadalafil in differenti classi di pazienti con disfunzione erettile: update dopo 6 mesi. Giornale Italiano di Andrologia, 2006, vol 13, p S13.
12.
Vardi Y, Appel B, Kilchevsky A, Gruenwald I: Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study. J Urol 2012;187:1769-1775.
13.
Ohebshalom M, Mulhall J, Guhring P, Parker M: Measurement of penile curvature in Peyronie's disease patients: comparison of three methods. J Sex Med 2007;4:199-203.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.